Optimal Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Optimal Asset Management’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$4.2M	Buy	5,626 +13	+0.2%	+$9.74K	0.52%	55
2021 Q2	$3.62M	Hold	5,613	–	–	0.43%	77
2021 Q1	$3.21M	Buy	5,613 +2,500	+80%	+$1.48M	0.42%	77
2020 Q4	$1.81M	Sell	3,113 -1	-0%	-$570	0.26%	135
2020 Q3	$1.6M	Buy	3,114 +1,195	+62%	+$605K	0.23%	143
2020 Q2	$866K	Sell	1,919 -592	-24%	-$261K	0.14%	237
2020 Q1	$880	Buy	2,511 +1,203	+92%	+$442K	0.08%	301
2019 Q4	$484K	Buy	+1,308	New	+$461K	0.07%	332

Other funds holding BIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Optimal Asset Management's BIO Position: Q3 2021 in Review

Optimal Asset Management increased its Bio-Rad Laboratories Class A (BIO) stake by 0.23% in Q3 2021, buying an estimated $9.74K and bringing the position to 5,626 shares worth $4.2M. The position accounts for 0.52% of the portfolio, ranked #55.

Optimal Asset Management first reported a position in BIO in Q4 2019 and has held it in 8 quarters since. 507 funds tracked by Wall St. Rank hold BIO as of Q3 2021.

Optimal Asset Management held 5,626 shares of Bio-Rad Laboratories Class A worth $4.2M as of Q3 2021.
Optimal Asset Management bought 13 Bio-Rad Laboratories Class A shares in Q3 2021, an estimated $9.74K.
Bio-Rad Laboratories Class A made up 0.52% of Optimal Asset Management's portfolio in Q3 2021, its #55 holding.
Optimal Asset Management first reported a position in Bio-Rad Laboratories Class A in Q4 2019 and has held it in 8 quarters since.
507 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2021.

Based on Optimal Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.